Compare Axogen Inc (AXGN) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Schwab US Dividend Equity ETF — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while Schwab US Dividend Equity ETF trades at $32.29. The key difference: Schwab US Dividend Equity ETF is trading nearer its 52-week high, Axogen Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | SCHD | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $46.19 | $32.83 |
52-Week Low | $11.28 | $26.38 |
Enterprise Value | $1.98B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
SCHD trades at $32.56, up 0.49% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF has recently underperformed the S&P 500 but shows strength in dividend-focused holdings, with nearly 30 components doubling the index's YTD return. A dividend of $0.25 is scheduled for June 2026, reinforcing its income appeal amid sideways price action since May.
Outlook remains favorable for income investors due to SCHD's high yield and dividend growth history, though competition from rising Treasury yields presents a risk. The ETF's low fee and quality stock selection support long-term wealth building, but market rotation away from value stocks could limit near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Schwab US Dividend Equity ETF
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →
